Involvement of Body Fluids in SARS-CoV-2 Infection
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "SARS-CoV-2 and COVID-19".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 3890
Special Issue Editor
Special Issue Information
Dear colleagues,
SARS-CoV-2 RNA, or infectious virions, have been detected in various body fluids and secretions such as respiratory aerosols, saliva, bronchoalveolar lavage, plasma, breast milk or feces. Whether or not virus transmissions via all of these body fluids can occur is not entirely understood, but might be dependent on the virus origin and titers in the respective fluid. Furthermore, components in the body fluid might directly impact virus infectivity and prevent or foster transmission.
In this Special Issue of Viruses, we want to explore how SARS-CoV-2 enters and behaves in different body fluids or how the different body fluids impact SARS-CoV-2 infectivity. Biological fluids might contain antiviral activities that are based on peptides, proteins, lipids, or extracellular vesicles. Such entities might directly influence virus stability and infectivity and thus transmissibility. The understanding of what environment virus transmissions are likely, or why some transmission routes can be excluded, might reveal points of vulnerability of SARS-CoV-2 and lead to the development of new antiviral strategies. Thus, we here want to accumulate data on virus-interfering or -promoting substances in body fluids and drive the development of antiviral strategies crucially required to fight this and future pandemics.
Dr. Janis Müller
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- emerging viruses
- virus transmission
- virus inhibition
- virucidal
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
